Background: In Klebsiella pneumoniae, loss-of-function mutations in the transcriptional repressors RamR and OqxR both have an impact on the production of efflux pumps and porins relevant to antimicrobial efflux/entry.
Introduction
Multiple envelope proteins contribute to antimicrobial susceptibility and resistance in Klebsiella pneumoniae. Two major porins, OmpK35 and OmpK36, are important for drug entry [1] [2] [3] [4] and the OmpK35/36 ratio is affected by osmolarity. 5 Drug efflux is mainly catalysed by the resistance nodulation cell division (RND)-type pump, AcrB, working with AcrA and TolC as a tripartite system. [6] [7] [8] AcrAB production is controlled by the transcriptional repressor AcrR and is up-regulated following overproduction of the AraC-type transcriptional activator RamA. 6, 9, 10 RamA overproduction also boosts transcription of micF, encoding an antisense RNA, which down-regulates OmpK35 porin production, and RamA up-regulates a second RND-type efflux pump, OqxAB. 10 RamA hyperproduction occurs in ramR loss-of-function mutants because RamR is a transcriptional repressor of ramA. [9] [10] [11] Loss-of-function mutations in the transcriptional repressor OqxR also activate oqxAB transcription, as well as transcription of rarA, which encodes a RamA orthologue. 11, 12 To add to this complexity, increased efflux pump and/or reduced porin production can confer an additive effect in combination with plasmid-mediated antimicrobial resistance proteins or target site mutations. This has been demonstrated for the complex interplay of factors that influence ciprofloxacin susceptibility 13 and in the generation of potentially important and perhaps clinically under-reported carbapenemasenegative carbapenem-resistant phenotypes. 10, 14 We have previously characterized the interplay between factors that confer RamA-mediated MDR in K. pneumoniae. 10 The aim of the work reported here was to analyse the importance of oqxR loss-of-function mutation in MDR and to identify the resistance proteins involved. 
Materials and methods

Bacterial strains and susceptibility testing
Four K. pneumoniae strains were used in the study: Ecl8, 15 plus in vitroselected loss-of-function mutants in oqxR (Tyr109STOP) or ramR (Thr124Pro) 13 and finally, Ecl8DramR 16 additionally carrying a gyrA QRDR (Ser83Phe) and an oqxR loss-of-function mutation (Arg93Cys). 13 E. coli XL10-Gold (Stratagene) was used for cloning. Disc susceptibility testing was performed according to CLSI methodology 17 and interpreted using CLSI performance standards. 18 Cloning genes, transformation and complementation studies
The WT oqxR and ramR genes of K. pneumoniae Ecl8 were amplified by PCR using the primers listed in Table S1 (available as Supplementary data at JAC Online). Each PCR amplicon was TA-cloned into pCR2.1-TOPO (Invitrogen) according to the manufacturer's instructions. The inserts were removed using EcoRI (for oqxR) or HindIII plus XbaI (for ramR) and ligated into pK18. 19 The rarA gene was PCR amplified from Ecl8 using primers listed in Table S1 and directly ligated into pBAD322K 20 after cutting with NcoI and XbaI. Cloning of plasmid-mediated b-lactamase genes bla CTX-M-1 and bla CMY-4 (with their native promoters) using the vector pSU18 10 and later subcloning into the vector pUBYT has previously been reported. 14 Recombinant plasmids were used to transform K. pneumoniae strains to kanamycin resistance (30 mg/L for pBAD322 and 50 mg/L for pUBYT) using electroporation. All strains and plasmids are recorded in Table S2 .
Quantitative analysis of envelope proteome via Orbitrap LC-MS/MS and quantitative RT-PCR
Each mutant and transformant was cultured in 50 mL CAMHB (Sigma) with appropriate antibiotic selection. Cultures were incubated with shaking (160 rpm) at 37 C until the OD at 600 nm reached 0.5-0.7. Total cellular RNA was purified and quantitative RT-PCR (qRT-PCR) was performed as previously described, 10, 21 using the primers listed in S1. Total envelope proteomics was performed as previously described. 10, 21 For each LC-MS/MS proteomics experiment, raw protein abundance data were collected for three biological replicates of each test condition. A paired t-test was used to calculate the significance of any difference in protein abundance in pooled data from the two test conditions. A P value of ,0.05 was considered significant. The fold change in abundance for each protein in the two test conditions was calculated using the averages of absolute abundances for the three biological replicates for the two test conditions.
Fluorescent Hoechst (H) 33342 dye accumulation assay
Envelope permeability was estimated as described previously 21 in bacteria grown in CAMHB using an established fluorescent dye accumulation assay. 22 The assay was performed using black, flat-bottomed 96-well plates (Greiner Bio-One, Stonehouse, UK) and a FLUOstar Optima (Aylesbury, UK) plate reader. H33342 dye (Sigma) was used at a final concentration of 2.5 lM.
Results and discussion
Relative impact of OqxR and RamR loss-of-function mutations on antimicrobial susceptibility and envelope permeability
We have recently reported in vitro selection of oqxR and ramR lossof-function mutants from the WT K. pneumoniae strain Ecl8. Table 1 reports the relative impacts of these mutations on inhibition zone diameter for a range of antimicrobials of different classes. As expected, the ramR point mutant phenotype was very similar to the profile seen for an Ecl8DramR mutant previously studied. 10 The oqxR mutation had a larger effect on fluoroquinolone and chloramphenicol susceptibility than the ramR mutation (68 mm versus 47 mm combined zone diameter reduction across five agents); the ramR mutation had a larger impact on cephalosporin susceptibility than the oqxR mutation (69 mm versus 46 mm combined zone diameter reduction across 10 agents). Both mutations conferred minocycline non-susceptibility though neither had any effect on the zone diameters around carbapenem or aminoglycoside discs.
Overall envelope permeability (a combination of outer membrane permeability and efflux) in the two mutants was similar. The steady-state accumulation of a fluorescent dye was 45% and 
Efflux pump and porin protein abundance changes in oqxR and ramR mutants
We used Orbitrap LC-MS/MS proteomics to define the impact of the ramR and oqxR mutations on the production of porins and efflux pumps previously implicated in antimicrobial drug resistance in K. pneumoniae. The OqxA and OqxB efflux pump proteins were found to be below the detection level in WT cells, but they were detectable in both the ramR and oqxR mutants, with up-regulation being almost two orders of magnitude greater in the latter (Figure 2c and d) . By contrast, up-regulation of AcrA and AcrB efflux pump proteins was only observed in the ramR mutant (Figure 2a and b) with similar fold increases to those reported recently for an Ecl8DramR mutant (4.79-versus 3.88-fold for AcrA and 3.56-versus 4.87-fold for AcrB). 10 Although it has not been confirmed experimentally in K. pneumoniae, TolC is likely to work as the outer membrane protein for both OqxAB and AcrAB. TolC levels were significantly up-regulated in both oqxR and ramR mutants relative to WT (Figure 2e ). Down-regulation of the OmpK35 porin was equally observed in both mutants: 0.43-fold, P " 0.005 (oqxR mutant) and 0.41-fold P " 0.005 (ramR mutant) (Figure 2f ). Significant changes in abundance of the OmpK36 porin were not observed in either mutant (Figure 2g) . A list of proteins for which abundance was significantly changed (2-fold, P , 0.05) in the oqxR or ramR mutant relative to Ecl8 during growth in CAMHB is shown in Tables S3  and S4 . Ten of 11 proteins previously shown to be significantly upregulated 2-fold upon deletion of ramR in Ecl8, irrespective of growth conditions, 10 were also regulated in the ramR point mutant; the only protein significantly down-regulated 2-fold in Ecl8DramR and the Ecl8 ramR point mutant was OmpK35 (Table S4) . Twelve of 23 proteins differentially regulated in the oqxR loss-of-function mutant (Table S3 ) during growth in CAMHB were also differentially regulated in the ramR mutant (Table S4) when grown in the same conditions.
To confirm the relative impacts of the oqxR and ramR mutations on efflux pump and porin production, we took a previously selected oqxR/ramR double mutant 13 and individually complemented either oqxR or ramR in trans. The double mutant produced levels of AcrAB similar to those in the ramR mutant and levels of OqxAB were similar to those in the oqxR mutant (Figures 2a-d and 3a-d) . We found TolC or OmpK35 production to be maximally altered in the oqxR or ramR single mutants because protein levels were similar in the oqxR/ramR double mutant to levels in the oqxR or ramR single mutants (Figures 2e-g and 3e-g ). However, the additive effect of the two regulatory mutations on AcrB/OqxB efflux pump protein production was enough to further reduce envelope permeability to 25% of WT, according to the fluorescent dye accumulation assay ( Figure S1 ). This is because, in protein abundance terms, AcrB and OqxB are limiting (Figure 2) . Complementation of either ramR or oqxR in the double mutant increased envelope permeability to 55% of WT ( Figure S1 ), the level of permeability seen in the single mutants (Figure 1 ), confirming that there are no other significant factors involved. Likewise, complementation of the double mutant with either oqxR or ramR resulted in a recombinant that produced efflux pump and porin proteins as expected given the remaining mutation (Figures 2a-d and 3a-d) .
Impact of RarA overproduction in the oqxR mutant
We have shown that oqxR loss has a large impact on OqxAB but no significant (P . 0.05) impact on AcrAB abundance (Figure 2 ). This would fit with OqxR being a local transcriptional repressor of oqxAB, as previously demonstrated. 11, 12 However, loss of oqxR significantly up-regulates TolC and reduces levels of OmpK35 (Figure 2 ). It has previously been shown that OqxR controls transcription of rarA, 12 encoding a RamA-like global transcriptional activator. 23 Accordingly, we hypothesized that the wider effects of oqxR loss in Ecl8 were caused by overexpression of rarA. qRT-PCR revealed that rarA expression is indeed up-regulated (417+127-fold) in the oqxR mutant. Expression of acrA does not significantly change (1.4+0.1-fold) in the oqxR mutant, as predicted from the proteomics (Figure 2) .
In order to dissect out the implications of RarA overproduction on the proteomic changes seen in the oqxR mutant, we cloned rarA without its promoter into pBAD322K 20 and set about Wan Nur Ismah et al.
overexpressing it by using arabinose induction. qRT-PCR confirmed rarA expression in Ecl8(pBAD322K:rarA) in the presence of 0.02% w/v arabinose was very similar (415+87.2 fold more than control) to that seen in the oqxR mutant. Key efflux and porin protein production levels following rarA overexpression at this level ( Figure S2 ) were very similar to those seen in the ramR loss-of-function mutant ( Figure 2 ) in which ramA, a close homologue of rarA, is overexpressed. 10 Based on the phenotype of the Ecl8 oqxR mutant (Figure 2) , the very different impact of rarA overexpression on protein levels in Ecl8 ( Figure S2 ) was surprising. Although rarA expression was the same in the oqxR loss-of-function mutant and in the rarA-overexpressing oqxR WT recombinant (see above), increased AcrAB production was only seen in the rarA-overexpressing oqxR WT recombinant (Figure 2 and Figure S2 ). The positive impact of rarA overexpression on acrAB expression in an oqxR WT background has also been reported by others. 12 We hypothesize that RarA preferentially binds to the oqxAB promoter, so when OqxR is not present-in the oqxR mutant-the overproduced RarA predominantly drives oqxAB expression and there is little impact on acrAB expression. However, when RarA is overproduced in a background when OqxR is located as a repressor on the oqxAB promoter (an artificial situation unlikely ever to be seen in a clinical isolate) RarA binds at less preferential sites, including the acrAB promoter.
Impact of OqxR loss of function in combination with plasmid-mediated cephalosporinases on carbapenem susceptibility
We have recently shown that ramR loss of function enhances the impact of carrying the serine active site cephalosporinases bla CTX-M-1 and bla CMY-4 , with particularly worrying effects on carbapenem susceptibility, including causing ertapenem resistance in some cases. 10, 14 To see whether OqxR loss has a similar impact, plasmids encoding bla CTX-M-1 or bla CMY-4 were used to transform our Ecl8 oqxR point mutant. There was a very slight impact on ertapenem susceptibility in comparison with Ecl8 transformants (Table S5) , but much less than that seen previously in an Ecl8DramR mutant. 10 This probably reflects the relatively low impact of oqxR loss on b-lactam susceptibility (Table 1) , because of its negligible impact on AcrAB efflux pump production ( Figure 2 ) and the fact that OqxAB is not a noted b-lactam efflux pump. Figure 2 . Abundance of key envelope proteins in K. pneumoniae Ecl8 WT and the oqxR and ramR mutants measured using LC-MS/MS proteomics. Values reported are absolute abundance values (%10 #7 , arbitrary units) recorded by the instrument used. Data are means (n " 3 biological replicates); error bars show the standard error of the mean. Asterisks represent a significant difference in abundance relative to the control based on the following rules: 2-fold difference in abundance and P , 0.05 for a t-test comparing absolute protein abundance data, n " 3.
OqxR loss in K. pneumoniae JAC PCR sequencing was used to identify oqxR mutations in a collection of 44 K. pneumoniae clinical isolates in which ramR sequence and b-lactamase complement had already been determined. 10 All oqxR mutants were confirmed to hyperproduce OqxAB using LC-MS/MS proteomics of whole cell extracts as previously described. 13 As expected from our work with Ecl8 transformants (Table S5) , there was no impact of the oqxR loss-of-function mutation on carbapenem susceptibility in isolates M and AD, which carry bla CTX-M-15 , though, as previously noted, loss of ramR causes ertapenem resistance in bla CTX-M-15 -carrying isolate T (Table S6) . 10 
Conclusions
It is known that oqxR loss of function causes oqxAB overexpression and this is associated with tigecycline resistance. 12, 25, 26 It is also known that rarA is overexpressed, and that when overproduced in a recombinant form, RarA can have a wide range of effects on the cell, including up-regulation of acrAB and tolC transcription. 21, 23 However, our use of proteomics has allowed the first analysis of the relative impact of these events on the abundance of efflux pump and porin proteins in K. pneumoniae and has allowed us to define the relative importance of oqxR and ramR loss-of-function , arbitrary units) recorded by the instrument used. Data are means (n " 3 biological replicates); error bars show the standard error of the mean. Asterisks represent a significant difference in abundance relative to control based on the following rules: 2-fold difference in abundance and P , 0.05 for a t-test comparing absolute protein abundance data, n " 3.
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mutations, which can both be found in clinical K. pneumoniae isolates. 13 Loss of OqxR has a dramatic effect on OqxAB efflux pump production, with the absolute abundance of OqxB in an oqxR mutant being similar to that of AcrB (2%10 9 units) ( Figure 2 ). The impact of this .10 000-fold up-regulation of OqxAB on antimicrobial susceptibility is, however, rather modest (Table 1 ). There is a strong effect on fluoroquinolone susceptibility, conferring ciprofloxacin resistance in the presence of other mechanisms. 13 OqxAB overproduction also causes chloramphenicol, minocycline and, reportedly, tigecycline resistance (Table 1) 25,26 but its overall impact on b-lactam susceptibility is low, even in the presence of a plasmidmediated cephalosporinase (Table 1; Tables S5 and S6 ). This limits the clinical importance of oqxR loss relative to ramR loss and is likely to be because there is a negligible effect of oqxR loss on AcrAB production (Figure 2) . Indeed, when AcrAB is overproduced only 5-fold more than WT levels, as seen in a ramR mutant, this confers ertapenem resistance in the presence of a cephalosporinase. 10 Our work here also adds support to our hypothesis that OmpK35 down-regulation is not particularly important for reducing b-lactam susceptiblity, 10 since OqxR loss and RamR loss both cause a similar down-regulation of OmpK35 (Figure 2 ) but very different effects on b-lactam susceptibility (Table 1;  Tables S5 and S6) .
We were slightly surprised that oqxR loss does not cause AcrAB up-regulation, because it has previously been shown that oqxR loss causes rarA overexpression 12 and that RarA overproduction from a recombinant system in an oqxR WT background causes AcrAB up-regulation.
12,23 Whilst we were able to reproduce these previous findings (Figure S2 ), the key here is that RarA overproduction in an OqxR WT background, as used previously to define the rarA regulon, 23 is not relevant to what happens in an oqxR loss-offunction mutant. The impact of RarA overproduction is less broad in an oqxR mutant because it predominantly acts as a positive feed-forward mechanism to dramatically activate oqxAB transcription, explaining the .10 000-fold up-regulation of OqxAB production seen (Figure 2 ) rather than taking on a highly pleotropic role. Nonetheless, RarA overproduction does have additional effects in the cell, even when overproduced owing to oqxR loss, and many of the genes controlled are also controlled by RamA (Table S3) . 
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